Limbic trial pits AI chatbot against human therapists
Source: endpoints.news
- Limbic, an AI therapy company, launches a clinical trial to prove its chatbot delivers better mental health treatment than human therapists.
- The trial involves 1,000 patients with depression and anxiety, comparing AI sessions to human therapy over 12 weeks.
- Success could expand AI's role in therapy, easing shortages of human therapists.
Limbic, a London-based startup, is running a head-to-head clinical trial pitting its AI chatbot against human therapists for treating depression and anxiety. The study tests if AI can match or beat humans on patient outcomes like symptom reduction. Key players include Limbic's CEO Conor Lynch and UK research partners. It matters because therapist shortages plague mental health care, and proven AI could scale access fast.